? Through this competitive renewal Yale University Department of Dermatology proposes to continue its strong track record of training future leaders of academic dermatology. Of the sixteen trainees supported for one or more years by this T32 program during the past ten years and who have completed their subspecialty and/or research training, thirteen (80%) subsequently received full-time appointments to academic departments or the federal government, with major basic and/or clinical research commitments for twelve of them. Our emphasis on the development of the research skills of MD and MD/PhD dermatologists will be maintained, although PhD candidates judged likely to make substantive contributions to investigative dermatology will be considered for unfilled positions. Our department provides an environment conducive to training research dermatologists: sixteen of the twenty-one fulltime primary Dermatology faculty are actively engaged in basic and/or clinical research and nine spend > 50% effort on such research activities. Facilitated by the NIH-sponsored Yale Skin Diseases Research Core Center, our Dermatology-based research faculty interacts extensively with other leading investigators with primary appointments in other Yale departments, including fourteen researchers designated as preceptors for this training program, six of whom hold joint appointments in Dermatology. Because we consider it most conducive to the trainees' development of intellectual independence and to the introduction of new scientific skills into the dermatology community, substantial exposure to outstanding Yale University basic scientists outside of our department will continue to be mandatory. As during the past two funding periods, each trainee will have two advisors, one inside and one outside the Dermatology Department. In the usual circumstance in which the principal laboratory experience is outside the department, under the mentorship of one of the designated non-dermatologist basic scientists or another equivalent individual, the Dermatology Department faculty advisor will monitor progress of the trainee and certify that the training program is relevant to the trainee's future in the specialty. In the event that the trainee works directly in a dermatology laboratory, the non-dermatology Yale advisor will ensure exposure to additional basic technology, scientific review, seminars and peer group interactions. Training opportunities will continue to be available throughout a broad range of research arenas relevant to cutaneous biology: e.g., cellular and molecular immunobiology of normal and malignant T cells, B cells and dendritic cells; autoimmunity; vaccine development; melanocyte biology and melanoma; keratinocyte biology and carcinogenesis; gene therapy; microvasculature structure/function and wound healing. ? ?

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Program Officer
Baker, Carl
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Yale University
Schools of Medicine
New Haven
United States
Zip Code
Perry, Curtis J; Muñoz-Rojas, Andrés R; Meeth, Katrina M et al. (2018) Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity. J Exp Med 215:877-893
Neubert, Natalie J; Schmittnaegel, Martina; Bordry, Natacha et al. (2018) T cell-induced CSF1 promotes melanoma resistance to PD1 blockade. Sci Transl Med 10:
Dragovic, Srdjan M; Agunbiade, Tolulope A; Freudzon, Marianna et al. (2018) Immunization with AgTRIO, a Protein in Anopheles Saliva, Contributes to Protection against Plasmodium Infection in Mice. Cell Host Microbe 23:523-535.e5
Greiling, Teri M; Dehner, Carina; Chen, Xinguo et al. (2018) Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus. Sci Transl Med 10:
Damsky, William; Thakral, Durga; Emeagwali, Nkiruka et al. (2018) Tofacitinib Treatment and Molecular Analysis of Cutaneous Sarcoidosis. N Engl J Med 379:2540-2546
Lilly, Evelyn; Bunick, Christopher G; Maley, Alexander M et al. (2018) More than keratitis, ichthyosis, and deafness: multisystem effects of lethal GJB2 mutations. J Am Acad Dermatol :
Wang, Jake; Perry, Curtis J; Meeth, Katrina et al. (2017) UV-induced somatic mutations elicit a functional T cell response in the YUMMER1.7 mouse melanoma model. Pigment Cell Melanoma Res 30:428-435
Damsky, W E; Bosenberg, M (2017) Melanocytic nevi and melanoma: unraveling a complex relationship. Oncogene 36:5771-5792
Damsky, William; King, Brett A (2017) JAK inhibitors in dermatology: The promise of a new drug class. J Am Acad Dermatol 76:736-744
Bunick, Christopher G; Milstone, Leonard M (2017) The X-Ray Crystal Structure of the Keratin 1-Keratin 10 Helix 2B Heterodimer Reveals Molecular Surface Properties and Biochemical Insights into Human Skin Disease. J Invest Dermatol 137:142-150

Showing the most recent 10 out of 90 publications